These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 17072896)
1. Systematic review and meta-analysis of clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982 to present. McClure DL; Valuck RJ; Glanz M; Hokanson JE Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):132-43. PubMed ID: 17072896 [TBL] [Abstract][Full Text] [Related]
2. Severity of statin-induced adverse effects on muscle and associated conditions: data from the DAMA study. Pedro-Botet J; Millán Núñez-Cortés J; Chillarón JJ; Flores-Le Roux JA; Rius J Expert Opin Drug Saf; 2016 Dec; 15(12):1583-1587. PubMed ID: 27645494 [TBL] [Abstract][Full Text] [Related]
3. Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients. Nichols GA; Koro CE Clin Ther; 2007 Aug; 29(8):1761-70. PubMed ID: 17919557 [TBL] [Abstract][Full Text] [Related]
4. Myopathy in older people receiving statin therapy: a systematic review and meta-analysis. Iwere RB; Hewitt J Br J Clin Pharmacol; 2015 Sep; 80(3):363-71. PubMed ID: 26032930 [TBL] [Abstract][Full Text] [Related]
8. The effect of lipophilicity and dose on the frequency of statin-associated muscle symptoms: A systematic review and meta-analysis. Irwin JC; Khalesi S; Fenning AS; Vella RK Pharmacol Res; 2018 Feb; 128():264-273. PubMed ID: 28943224 [TBL] [Abstract][Full Text] [Related]
11. Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association. Newman CB; Preiss D; Tobert JA; Jacobson TA; Page RL; Goldstein LB; Chin C; Tannock LR; Miller M; Raghuveer G; Duell PB; Brinton EA; Pollak A; Braun LT; Welty FK; Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):e38-e81. PubMed ID: 30580575 [TBL] [Abstract][Full Text] [Related]
12. Rhabdomyolysis with HMG-CoA reductase inhibitors and gemfibrozil combination therapy. Chang JT; Staffa JA; Parks M; Green L Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):417-26. PubMed ID: 15269925 [TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis and HMG-CoA reductase inhibitors. Omar MA; Wilson JP; Cox TS Ann Pharmacother; 2001 Sep; 35(9):1096-107. PubMed ID: 11573861 [TBL] [Abstract][Full Text] [Related]
15. Statin myopathy: a common dilemma not reflected in clinical trials. Fernandez G; Spatz ES; Jablecki C; Phillips PS Cleve Clin J Med; 2011 Jun; 78(6):393-403. PubMed ID: 21632911 [TBL] [Abstract][Full Text] [Related]
16. Rhabdomyolysis and statin therapy: relevance to the elderly. Sica DA; Gehr TW Am J Geriatr Cardiol; 2002; 11(1):48-55. PubMed ID: 11773716 [TBL] [Abstract][Full Text] [Related]
17. Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism. Golomb BA; Evans MA Am J Cardiovasc Drugs; 2008; 8(6):373-418. PubMed ID: 19159124 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818 [TBL] [Abstract][Full Text] [Related]
19. Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials. Ott BR; Daiello LA; Dahabreh IJ; Springate BA; Bixby K; Murali M; Trikalinos TA J Gen Intern Med; 2015 Mar; 30(3):348-58. PubMed ID: 25575908 [TBL] [Abstract][Full Text] [Related]
20. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same? Evans M; Rees A Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]